Biotage AB (publ) announced that while the business of the company continues to perform well, following consultation with the Board Tomas Blomquist will leave his role as CEO & President of the company with immediate effect. The Chairman of the Board, Torben Jørgensen, has been appointed by the Board of Directors as interim CEO while the process of recruiting a new CEO is finalized. As Torben Jørgensen takes on the role as interim CEO, he has resigned as Chairman of the Board but he will remain as a Board member.